
Marine Compound Rutamycin B Offers Faster Defense Against Fatal Brain Amoeba
Researchers at UC San Diego identified rutamycin B, a compound from marine bacteria, as a potential treatment for Naegleria fowleri. The substance kills the amoeba in four hours, significantly faster than current treatments, and is highly selective against human cells. While promising, the compound remains in early lab stages and requires further testing to ensure it can reach the brain effectively.